Indrayani Biotech Limited reported earnings results for the first quarter ended June 30, 2023. For the first quarter, the company reported sales was INR 423.13 million compared to INR 256.32 million a year ago. Revenue was INR 423.21 million compared to INR 260.26 million a year ago.

Net loss was INR 4.46 million compared to net income of INR 17.89 million a year ago. Diluted loss per share from continuing operations was INR 0.09 compared to diluted earnings per share from continuing operations of INR 0.52 a year ago.